The therapeutic value of maintenance tocolysis: an overview of the evidence.
The results obtained from current systematic overview do not support the routine administration of maintenance tocolytic treatment after parenteral tocolytic therapy has halted acute preterm labor. Eliminating or reducing such routine maintenance therapy, therefore, could substantially decrease costs and side effects associated with managing preterm labor without compromising perinatal outcomes. It remains to be elucidated whether it will become possible to accurately identify some groups of pregnancies for which maintenance tocolysis would be beneficial.
Sanchez-Ramos
Luis
L
Division of Maternal-Fetal Medicine University of Florida Health Science Center, 653-1 West 8th Street, Jacksonville, FL 32209, USA. luis.sanchez@jax.ufl.edu
Huddleston
John F
JF
D005260:Female; D006801:Humans; D007752:Obstetric Labor, Premature / Q000517:prevention & control / Q000628:therapy*; D011247:Pregnancy; D011256:Pregnancy Outcome; D016032:Randomized Controlled Trials as Topic; D015145:Tocolysis / Q000379:methods; D015149:Tocolytic Agents / Q000627:therapeutic use*; D014590:Uterine Contraction / Q000187:drug effects*
D015149:Tocolytic Agents